3-Prenyl-2,4,6-trihydroxybenzophenoneCAS# 93796-20-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 93796-20-4 | SDF | Download SDF |
| PubChem ID | 14282624 | Appearance | Yellow powder |
| Formula | C18H18O4 | M.Wt | 298.3 |
| Type of Compound | Xanthones | Storage | Desiccate at -20°C |
| Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
| Chemical Name | phenyl-[2,4,6-trihydroxy-3-(3-methylbut-2-enyl)phenyl]methanone | ||
| SMILES | CC(=CCC1=C(C=C(C(=C1O)C(=O)C2=CC=CC=C2)O)O)C | ||
| Standard InChIKey | WKFZVPVRFGJMEY-UHFFFAOYSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Structure Identification | Synthetic Communications, 2017, 47(6):599-603.Synthesis of 3-geranyl- and 3-prenyl-2,4,6-trihydroxybenzophenone.[Reference: WebLink]
|
3-Prenyl-2,4,6-trihydroxybenzophenone Dilution Calculator
3-Prenyl-2,4,6-trihydroxybenzophenone Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 3.3523 mL | 16.7616 mL | 33.5233 mL | 67.0466 mL | 83.8082 mL |
| 5 mM | 0.6705 mL | 3.3523 mL | 6.7047 mL | 13.4093 mL | 16.7616 mL |
| 10 mM | 0.3352 mL | 1.6762 mL | 3.3523 mL | 6.7047 mL | 8.3808 mL |
| 50 mM | 0.067 mL | 0.3352 mL | 0.6705 mL | 1.3409 mL | 1.6762 mL |
| 100 mM | 0.0335 mL | 0.1676 mL | 0.3352 mL | 0.6705 mL | 0.8381 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Roxatidine Acetate HCl
Catalog No.:BCC4534
CAS No.:93793-83-0
- gamma-Secretase Modulators
Catalog No.:BCC1586
CAS No.:937812-80-1
- Neurodazine
Catalog No.:BCC7738
CAS No.:937807-66-4
- Neogambogic acid
Catalog No.:BCN2321
CAS No.:93772-31-7
- Jangomolide
Catalog No.:BCN4483
CAS No.:93767-25-0
- GRP (human)
Catalog No.:BCC5810
CAS No.:93755-85-2
- Magnaldehyde D
Catalog No.:BCN4070
CAS No.:93753-33-4
- Pacritinib (SB1518)
Catalog No.:BCC4558
CAS No.:937272-79-2
- SB1317
Catalog No.:BCC1925
CAS No.:937270-47-8
- ARRY-380
Catalog No.:BCC3726
CAS No.:937265-83-3
- NSC 95397
Catalog No.:BCC7109
CAS No.:93718-83-3
- GSK690693
Catalog No.:BCC2483
CAS No.:937174-76-0
- 22-beta-Acetoxyglycyrrhizin
Catalog No.:BCN7904
CAS No.:938042-17-2
- ATPγS tetralithium salt
Catalog No.:BCC7855
CAS No.:93839-89-5
- KU-0063794
Catalog No.:BCC2484
CAS No.:938440-64-3
- Isochamaejasmine
Catalog No.:BCN3128
CAS No.:93859-63-3
- 9-Oxo-2,7-bisaboladien-15-oic acid
Catalog No.:BCN4484
CAS No.:93888-59-6
- FIPI
Catalog No.:BCC7721
CAS No.:939055-18-2
- Hirsutanonol 5-O-glucoside
Catalog No.:BCN4485
CAS No.:93915-36-7
- Toonaciliatin M
Catalog No.:BCN7881
CAS No.:93930-04-2
- Fluvastatin
Catalog No.:BCC1579
CAS No.:93957-54-1
- Fluvastatin Sodium
Catalog No.:BCC2317
CAS No.:93957-55-2
- [Ac-Tyr1,D-Phe2]GRF 1-29, amide (human)
Catalog No.:BCC5719
CAS No.:93965-89-0
- PF-00562271
Catalog No.:BCC3684
CAS No.:939791-38-5
Induction of apoptosis of 2,4',6-trihydroxybenzophenone in HT-29 colon carcinoma cell line.[Pubmed:24579081]
Biomed Res Int. 2014;2014:468157.
2,4',6-Trihydroxy-4-methoxybenzophenone was isolated from the ethyl acetate fraction of Phaleria macrocarpa (Scheff.) Boerl. fruits. It was found to inhibit cell proliferation in HT-29 human colon carcinoma cell line but caused little damage to WRL-68 normal human liver and MRC-5 normal human fibroblast lung cell lines. The compound was found to sharply affect the viability of HT-29 cells in a dose- and time-dependent manner. HT-29 cells treated with the compound showed morphological changes under microscopic examination such as cell shrinkage, membrane blebbing, DNA fragmentation, and the occurrence of apoptotic nuclei. The percentage of early apoptotic, late apoptotic, and dead or necrotic cells was determined by flow cytometry using annexin V-FTIC/PI staining. In addition, flow cytometry showed that, when the HT-29 cells were treated with 115 microM of the compound, it resulted in G0/G1 phase arrest in a time-dependent manner. Western blot revealed an upregulation of PUMA, Bak, Bcl-2, and Mcl-1 proteins suggesting that the compound induced apoptosis in HT-29 cells by regulating these proteins.
